Suppr超能文献

粒径对环孢素 A 纳米混悬剂吸收的影响。

The Effect of Particle Size on the Absorption of Cyclosporin A Nanosuspensions.

机构信息

Department of Pharmaceutics, Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, People's Republic of China.

Bengbu Medical College, Bengbu, People's Republic of China.

出版信息

Int J Nanomedicine. 2022 Apr 19;17:1741-1755. doi: 10.2147/IJN.S357541. eCollection 2022.

Abstract

BACKGROUND

Cyclosporin A (CsA) is a hydrophobic drug widely used as an immunosuppressant and anti-rejection drug in solid organ transplantation. On the market, there are two oral CsA formulations available containing polyoxyethylene castor oil, which can cause serious allergic reactions and nephrotoxicity. In order to eliminate polyoxyethylene castor oil, CsA was formulated into a nanosuspension. This study aimed to design an oral cyclosporin A nanosuspensions (CsA-NSs) and investigate the effect of particle size on absorption of CsA-NSs.

METHODS

CsA-NSs were prepared using a wet bead milling method. Particle size, morphology and crystallinity state of CsA-NSs were characterized. The in vitro dissolution, the intestinal absorption properties and pharmacokinetic study of CsA-NSs were investigated.

RESULTS

CsA-NSs with sizes of 280 nm, 522 nm and 2967 nm were prepared. The shape of CsA-NSs with smaller size was similar to that of spheres. The crystallinity of CsA in nanocrystals was reduced. The dissolution rate of CsA-NSs (280 nm) was greater than that of CsA-NSs (522 nm) and CsA-NSs (2967 nm). CsA-NSs (280 nm) showed higher absorption rate constants ( ) and effective permeability coefficients ( ) of different intestinal segments compared with that of CsA-NSs (522 nm) and CsA-NSs (2967 nm). AUC of 280 nm CsA-NSs was about 1.12-fold of that of 522 nm CsA-NSs, and about 1.51-fold of that of 2967 nm CsA-NSs. In particular, the particle size of CsA-NSs was nanoscale, and their bioavailability was bioequivalent with marked self-microemulsion (Sandimmun Neoral).

CONCLUSION

It is feasible to prepare CsA-NSs. The dissolution rate, gastrointestinal transport properties and the oral absorption of CsA-NSs were promoted by reducing size. Considering the cost, efficiency and energy consumption, there should be an optimal particle size range in industrial production.

摘要

背景

环孢素 A(CsA)是一种疏水性药物,广泛用作实体器官移植中的免疫抑制剂和抗排斥药物。市场上有两种含有聚氧乙烯蓖麻油的口服 CsA 制剂,可引起严重的过敏反应和肾毒性。为了消除聚氧乙烯蓖麻油,将 CsA 制成纳米混悬剂。本研究旨在设计口服环孢素 A 纳米混悬剂(CsA-NSs)并研究粒径对 CsA-NSs 吸收的影响。

方法

采用湿磨法制备 CsA-NSs。对 CsA-NSs 的粒径、形态和结晶状态进行了表征。考察了 CsA-NSs 的体外溶出度、肠道吸收特性和药代动力学研究。

结果

制备了粒径为 280nm、522nm 和 2967nm 的 CsA-NSs。较小粒径的 CsA-NSs 的形状类似于球体。纳米晶体中 CsA 的结晶度降低。CsA-NSs(280nm)的溶出速率大于 CsA-NSs(522nm)和 CsA-NSs(2967nm)。与 CsA-NSs(522nm)和 CsA-NSs(2967nm)相比,CsA-NSs(280nm)在不同肠段的吸收速率常数( )和有效渗透系数( )更高。280nm CsA-NSs 的 AUC 约为 522nm CsA-NSs 的 1.12 倍,约为 2967nm CsA-NSs 的 1.51 倍。特别是,CsA-NSs 的粒径为纳米级,其生物利用度与具有显著自微乳(Sandimmun Neoral)的生物等效。

结论

制备 CsA-NSs 是可行的。通过减小粒径,提高了 CsA-NSs 的溶解速率、胃肠道转运特性和口服吸收。考虑到成本、效率和能耗,在工业生产中应有一个最佳的粒径范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f452/9034871/566a47518d06/IJN-17-1741-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验